Back to search
FDAFDA · Food and drugs·Recall number D-1384-2012

Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.

Published June 27, 2012 · Recall initiated: April 23, 2012

Summary

FDA records drug Class III recall D-1384-2012, published June 27, 2012 and initiated April 23, 2012. Recalling firm: Teva Pharmaceuticals USA, Inc.; Status: Terminated; Reported quantity: 40,750 Dispensers; Lot: Lot #'s 33801826A, Exp 1/2013; 33802144A; 33802323A, Exp 3/2013; 33802519A, Exp 6/2013. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email if JOLESSA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
JOLESSA
Manufacturer
Teva Pharmaceuticals USA, Inc.
Distributor
Nationwide
Lot
Lot #'s 33801826A, Exp 1/2013; 33802144A; 33802323A, Exp 3/2013; 33802519A, Exp 6/2013
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66. recalled?

Yes. FDA published recall D-1384-2012 on June 27, 2012. Reported hazard: Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: JOLESSA.